Beschreibung
Funnel plot analysis evaluates publication bias across the studies included in the systematic review of omega-3 fatty acids for Alzheimer's disease.
More Figures from This Paper
Figure 2
Forest plot of randomized controlled trials evaluates the pooled effect of omega-3, DHA, and EPA supplementation on cognitive function scores in Alzheimer's disease patients.
forest_plot
Figure 3
Subgroup analysis by intervention type separates the effects of pure omega-3 supplements from the multinutrient Souvenaid formulation on Alzheimer's disease outcomes.
forest_plot
Figure 4
Forest plot assessing the impact of omega-3 supplementation on functional daily living activities in Alzheimer's disease patients across included trials.
forest_plot
Figure 5
Risk of bias assessment for included studies is visualized using the Cochrane tool, indicating overall moderate quality of evidence across the meta-analysis.
chartFigure 6
ChartSource Paper
The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis.Cite This Figure
 > Source: Ernesto Calderon Martinez et al. "The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systemati." *Neuropsychopharmacology reports*, 2024. PMID: [38924283](https://pubmed.ncbi.nlm.nih.gov/38924283/)
<figure> <img src="https://pdfs.citedhealth.com/figures/38924283/232.png" alt="Funnel plot analysis evaluates publication bias across the studies included in the systematic review of omega-3 fatty acids for Alzheimer's disease." /> <figcaption>Figure 6. Funnel plot analysis evaluates publication bias across the studies included in the systematic review of omega-3 fatty acids for Alzheimer's disease.<br> Source: Ernesto Calderon Martinez et al. "The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systemati." <em>Neuropsychopharmacology reports</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38924283/">38924283</a></figcaption> </figure>